Target intelligence / Profile preview

Nucleocapsid phosphoprotein (N protein) (N protein)

Target
N protein
Molecular classification
Viral protein, RNA-binding protein, Phosphoprotein, Structural protein
01

Overview

The Nucleocapsid phosphoprotein (N protein) is a multifunctional structural protein essential for the life cycle of coronaviruses, including SARS-CoV-2 (UniProt: P0DTC9). Its primary function is to package the viral RNA genome into a ribonucleoprotein (RNP) complex, ensuring the protection and efficient assembly of the viral particle (PubMed: 32814526). The protein consists of two conserved domains—the N-terminal RNA-binding domain and the C-terminal dimerization domain—linked by a disordered, highly phosphorylated region that regulates its activity and interaction with other viral proteins (PubMed: 32558645). In addition to its structural duties, the N protein acts as an interferon antagonist, helping the virus evade the host's innate immune system (PubMed: 33053430). Clinically, it serves as a vital biomarker for diagnostic antigen tests and serological surveys, as it is expressed at high levels during infection (PubMed: 32730415). Therapeutic strategies targeting the N protein focus on small molecules that disrupt its ability to bind RNA or dimerize, offering a potential alternative or supplement to Spike-targeted vaccines and treatments (PubMed: 33503314).

Other names
NucleoproteinProtein NN-proteinNucleocapsid protein
02

Mechanism of action

Inhibition of RNA-binding affinity, disruption of protein dimerization, and interference with the formation of the ribonucleoprotein complex to prevent viral replication and assembly.

03

Biological functions

Viral genome packagingRNA synthesisRibonucleoprotein complex formationInterferon antagonismViral assemblyLiquid-liquid phase separation
04

Disease associations

InfectionCOVID-19Severe Acute Respiratory Syndrome (SARS)Middle East Respiratory Syndrome (MERS)
05

Safety considerations

Potential for off-target effects on host RNA-binding proteins (PubMed: 33053430)High viral load requirements for detectionEvolutionary mutations affecting binding affinityCross-reactivity with other coronaviruses (PubMed: 32659780)
06

Interacting drugs

Naproxen (PubMed: 33031759)

3 more in the full profile.

07

Biomarkers

Nucleocapsid antigen (PubMed: 32730415)Anti-nucleocapsid immunoglobulin G (IgG) (PubMed: 32422627)Anti-nucleocapsid immunoglobulin M (IgM) (PubMed: 32422627)

Beyond the preview

Go deeper on Nucleocapsid phosphoprotein (N protein) (N protein).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nucleocapsid phosphoprotein (N protein) (N protein).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call